US Patent Issued to SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS on Sept. 29 for "Compositions for the treatment of rheumatoid arthritis and methods of using same" (American, French Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,487, issued on Sept. 29, was assigned to SANOFI BIOTECHNOLOGY (Gentilly, France) and REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Compositions for the treatment of rheumatoid arthritis and methods of using same" was invented by Xiaohong Huang (Cambridge, Mass.), Martine Jasson (Paris), Vanessa Marks (Paris) and Allen Radin (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD."

The patent...